Alnylam Pharmaceuticals Inc (ALNY)
Market Closed
15 Oct, 08:00 PM
$
234. 03
+9.56
+4.2589%
$
31.13B Market Cap
- P/E Ratio
- Div Yield
1.26M Volume
-3.56 Eps
$ 224.47
Previous Close 
Want to track ALNY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alnylam Pharmaceuticals Inc (ALNY) Statistics
Valuation metrics
Market Cap 31.13B
Enterprise value 30.69B
Trailing P/E (ttm) 38.14
Forward P/E 21.35
PEG ratio 0.01
Price/Sales (ttm) 6.48
Price/Book (mrq) 22.9
Enterprise Value/Revenue 6.39
Enterprise Value/EBITDA 26.67
Overview
Shares outstanding 133.44M
Float 132.96M
Shares short 5.03M
% Held by insiders 0%
% Held by institutions 1.01%
Average volume (10 days) 1.34M
Average volume (90 days) 1.97M
Price summary
52-Week low 197.81
52-Week high 495.55
Beta 0.3
50-Day moving average 244.34
200-Day moving average 292
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.17%
Operating margin 0.21%
Operational effectiveness
Return on assets 0.15%
Return on equity 0.94%
Income Statement
Revenue (ttm) 4.29B
Revenue per share (ttm) 36.06
Quarterly revenue growth (yoy) 0.96%
Gross profit (ttm) 3.46B
EBITDA 909.4M
Net income to common (ttm) 537.99M
Diluted EPS (ttm) 6.06
Quarterly earnings growth (yoy) 0.96%
Balance Sheet
Total cash (mrq) 3.01B
Total cash per share (mrq) 24.83
Total debt (mrq) 2.97B
Total Debt/Equity (mrq) 0.94
Current ratio (mrq) 3.05%
Book value per share (mrq) 10.16
Cash Flow
Cash flow statement 714.9M
Levered free cash flow (LFCF) 204.71M
2026 © Marketlog. All Rights Reserved.
